Negative regulation of protein localization to nucleus

pathway activity — cross-omics
GO:1900181Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of protein localization to nucleus pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PCBD2, CYP4X1, and TRIM29, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of protein localization to nucleus activity versus PCBD2 in GBM (Pearson r = -0.13).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMPCBD2 →-0.380-0.165.002.00534
BRCACYP4X1 →-1.439-0.568.004.00534
BRCATRIM29 →+1.120+0.692<.001<.00134
BRCAKRT16 →+1.930+0.641<.001.00234
HNSCSPRR1B →+2.280+0.488.001.00434
LUADTTL →+0.321+0.714.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1900181 vs PCBD2 — GBM

Per-sample scatter of Negative regulation of protein localization to nucleus activity vs PCBD2 in GBM.

Explore this scatter interactively →

Exploration